ArticleEuropean heart journal. Case reports2025
Malignant fibrous histiocytoma of the heart: a rare case report of an aggressive cardiac sarcoma mimicking myxoma.
Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Left atrial primary intimal sarcoma mimicking myxoma: case report.European heart journal. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Primary cardiac tumours are rare, with an incidence ranging from 0.001% to 0.03%. Among these, sarcomas constitute the majority of malignant cases, with malignant fibrous histiocytoma (MFH) being one of the least commonly reported and most aggressive forms. Case summary: We present the case of a 40-year-old female who experienced non-specific symptoms, including malaise, dyspnoea, and recurrent chest pain. Initial investigations, including echocardiography, revealed a large mass in the left atrium, initially diagnosed as a myxoma. However, histopathological examination following surgical resection confirmed the diagnosis of MFH. Despite surgical intervention and chemotherapy, the tumour recurred, resulting in the patient's death 2 months after surgery. Discussion: Cardiac sarcomas, particularly MFH, pose significant diagnostic challenges due to their rarity and non-specific symptoms. These malignant tumours often mimic benign conditions, clinically and diagnostically, in modalities such as transoesophageal echocardiography and transthoracic echocardiography. While advanced imaging techniques are critical for accurate diagnosis, socioeconomic factors may limit access. Histopathological examination remains the gold standard for definitive diagnosis. The aggressive nature of these tumours, characterized by rapid recurrence and poor prognosis, highlights the need for improved diagnostic and therapeutic strategies. Future research should focus on targeted therapies and immunotherapy, which promise to improve outcomes in managing these malignancies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.